<DOC>
	<DOCNO>NCT00417872</DOCNO>
	<brief_summary>The primary objective demonstrate non-inferiority nitazoxanide administer 500 mg b.i.d compare metronidazole administer 250 mg q.i.d . resolve symptoms Clotridium difficile colitis seven day treatment . Secondary objective provide information time first dose last unformed stool resolution symptom colitis , sustain response rate different tratment group effect treatment Clostridium difficile toxin enzyme immunoassay/culture result hospitalization .</brief_summary>
	<brief_title>Study Nitazoxanide Treatment Clostridium Difficile Colitis</brief_title>
	<detailed_description />
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Age ≥ 18 year . Inpatients new onset colitis evidence diarrhea ( ≥3 unformed stool within 24 hour ) , one following : abdominal pain cramp ; peripheral leukocytosis , otherwise unexplained ; fever , otherwise unexplained . C. difficile toxin A B detect stool specimen obtain within 7 day enrollment enzyme immunoassay . Patients able take oral medication . Patients willing avoid follow medication study : oral intravenous metronidazole , oral vancomycin , antiperistaltic drug , opiate , Saccharomyces cerevisiae ( baker ’ yeast ) , Lactobacillus GC , cholestyramine colestipol . [ Patients opiate may include study long take opiate prior enrollment dose increase study ] . Patients willing abstain alcohol 10day treatment duration two day follow treatment . Patients known cause diarrhea colitis ( e.g. , Shigella , Salmonella , Cryptosporidium parvum , Giardia lamblia , Entamoeba histolytica , inflammatory bowel disease , irritable bowel syndrome , advance AIDS chemotherapy malignancy ) . Use within 1 week enrollment drug therapy antiC . difficile activity oral intravenous metronidazole oral vancomycin . [ Patients take 2 dos metronidazole vancomycin include study ] . Females child bear age either pregnant , breastfeed use birth control . A double barrier method , oral birth control pill administer least 2 monthly cycle prior study drug administration , IUD , medroxyprogesterone acetate administer intramuscularly minimum one month prior study drug administration acceptable method birth control inclusion study . In addition , female patient childbearing potential baseline pregnancy test agree continue acceptable method birth control duration study ( include followup ) . Patients take phenytoin , celecoxib , and/or losartan . [ Patients take Coumadin® ( warfarin ) may include long prothrombin time monitor least twice weekly first 2 week study least weekly thereafter ] . Patients severe renal hepatic impairment . Patients clinically unstable ( e.g. , patient sign toxic megacolon imminent perforation ) . Serious systemic disorder incompatible study . History hypersensitivity metronidazole .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Clostridium difficile</keyword>
</DOC>